Reducing Residual Depressive Symptoms With Web-based Mindful Mood Balance

Completed · Not applicable

Conditions studied: Major Depressive Disorder, Recurrent, in Remission, Depressive Symptoms

In brief

Many patients report residual depressive symptoms despite seemingly successful treatment. With the investigators' previous funding, we developed - Mindful Mood Balance - an online treatment that targets RDS by teaching specific emotion regulation and depression self-management skills that are entirely compatible with antidepressant treatment. The investigators now propose a controlled study to determine whether MMB is more effective than usual care at reducing RDS and other key outcomes. If successful, MMB's online delivery format would provide high fidelity and low-cost empirically supported management of residual symptoms, leading to more robust remission, improved functioning and sustained recovery from MDD over time.

Key facts

Study ID

NCT02190968

Run by

University of Toronto

People needed

460

Starts

2015-03-01

Expected to finish

2018-11-01

Last updated by the study team

2019-01-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with a PHQ-9 score between 5 and 9
• At least one prior episode of MDD

You may not qualify if…

• presence of schizophrenia or current psychosis, organic mental disorder or pervasive developmental delay

Where it is running

• Kaiser Permanente Institute for Health Research — Denver, Colorado, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.